[go: up one dir, main page]

FR20C1027I2 - Derives de tiglien-3-one - Google Patents

Derives de tiglien-3-one

Info

Publication number
FR20C1027I2
FR20C1027I2 FR20C1027C FR20C1027C FR20C1027I2 FR 20C1027 I2 FR20C1027 I2 FR 20C1027I2 FR 20C1027 C FR20C1027 C FR 20C1027C FR 20C1027 C FR20C1027 C FR 20C1027C FR 20C1027 I2 FR20C1027 I2 FR 20C1027I2
Authority
FR
France
Prior art keywords
tiglien
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR20C1027C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QBiotics Pty Ltd
Original Assignee
QBiotics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005907278A external-priority patent/AU2005907278A0/en
Application filed by QBiotics Pty Ltd filed Critical QBiotics Pty Ltd
Publication of FR20C1027I1 publication Critical patent/FR20C1027I1/fr
Application granted granted Critical
Publication of FR20C1027I2 publication Critical patent/FR20C1027I2/fr
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/20Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom three- or four-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N45/00Biocides, pest repellants or attractants, or plant growth regulators, containing compounds having three or more carbocyclic rings condensed among themselves, at least one ring not being a six-membered ring
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/32Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • C07D303/17Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals containing oxirane rings condensed with carbocyclic ring systems having three or more relevant rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • C07D303/44Esterified with oxirane-containing hydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR20C1027C 2005-12-23 2020-07-01 Derives de tiglien-3-one Active FR20C1027I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2005907278A AU2005907278A0 (en) 2005-12-23 Tiglien-3-one derivatives
PCT/AU2006/002001 WO2007070985A1 (fr) 2005-12-23 2006-12-22 Derives de tiglien-3-one

Publications (2)

Publication Number Publication Date
FR20C1027I1 FR20C1027I1 (fr) 2020-10-02
FR20C1027I2 true FR20C1027I2 (fr) 2021-06-11

Family

ID=38188192

Family Applications (1)

Application Number Title Priority Date Filing Date
FR20C1027C Active FR20C1027I2 (fr) 2005-12-23 2020-07-01 Derives de tiglien-3-one

Country Status (18)

Country Link
US (8) US8598229B2 (fr)
EP (1) EP1971588B1 (fr)
JP (1) JP5374158B2 (fr)
CN (1) CN101384575B (fr)
AU (1) AU2006326872C1 (fr)
CA (1) CA2634469C (fr)
DK (1) DK1971588T3 (fr)
ES (1) ES2391296T3 (fr)
FR (1) FR20C1027I2 (fr)
HK (1) HK1122568A1 (fr)
HU (1) HUS000506I2 (fr)
LU (1) LUC00164I2 (fr)
NL (1) NL301055I2 (fr)
NZ (1) NZ597019A (fr)
PL (1) PL1971588T3 (fr)
PT (1) PT1971588E (fr)
SI (1) SI1971588T1 (fr)
WO (1) WO2007070985A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1971588T3 (pl) 2005-12-23 2013-01-31 Qbiotics Ltd Pochodne tiglien-3-onu
MX340846B (es) * 2012-01-27 2016-07-28 Rhein Siegfried Sa De Cv Composición de nitazoxanida mejorada y proceso para prepararla.
JP6415538B2 (ja) 2013-04-18 2018-10-31 キューバイオティクス リミテッド 創傷治癒のための方法および組成物
WO2016150860A1 (fr) 2015-03-20 2016-09-29 Phyton Biotech Gmbh Production d'ingénol, d'esters d'ingénol et/ou de dérivés de tiglian-3-one par des cultures cellulaires de plantes d'euphorbiacées en suspension
CN105194126A (zh) * 2015-09-23 2015-12-30 青岛市中心医院 一种巴豆生物碱在制备治疗肺癌的药物中的应用
BR112019001365A2 (pt) * 2016-07-28 2019-04-30 Qbiotics Limited método de tratamento
PL3600281T3 (pl) * 2017-03-23 2023-09-11 QBiotics Pty Ltd Terapia skojarzona w leczeniu i profilaktyce nowotworów
EP3815281A4 (fr) 2018-06-28 2021-11-03 ZTE Corporation Configuration de liaison de transmission à l'aide d'un mappage de signal de référence
BR112021020253A2 (pt) 2019-04-12 2021-12-07 QBiotics Pty Ltd Método para tratar tumores
MX2021015673A (es) * 2019-06-19 2022-02-03 QBiotics Pty Ltd Alteracion de biopelicula.
US20240132460A1 (en) * 2021-03-10 2024-04-25 The Board Of Trustees Of The Leland Stanford Junior University Synthesis of tigilanol tiglate and analogs thereof
MX2024007679A (es) * 2021-12-21 2024-07-09 QBiotics Pty Ltd Compuestos intermedios cristalinos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001139468A (ja) * 1999-11-11 2001-05-22 Lead Chemical Co Ltd 抗ウイルス作用を有するホルボール誘導体
PL1971588T3 (pl) * 2005-12-23 2013-01-31 Qbiotics Ltd Pochodne tiglien-3-onu
WO2011086424A1 (fr) * 2010-01-15 2011-07-21 Amazonia Fitomedicamentos Ltda Utilisation pharmaceutique de mélanges de composés à plusieurs cycles comme agents concomitants anticancéreux, anti-inflammatoires et anti-douleur
PL3600281T3 (pl) * 2017-03-23 2023-09-11 QBiotics Pty Ltd Terapia skojarzona w leczeniu i profilaktyce nowotworów
BR112021020253A2 (pt) * 2019-04-12 2021-12-07 QBiotics Pty Ltd Método para tratar tumores
MX2021015673A (es) * 2019-06-19 2022-02-03 QBiotics Pty Ltd Alteracion de biopelicula.

Also Published As

Publication number Publication date
CA2634469C (fr) 2012-08-21
US20200179325A1 (en) 2020-06-11
EP1971588A4 (fr) 2011-03-02
HUS000506I2 (hu) 2021-03-29
NZ597019A (en) 2013-11-29
JP5374158B2 (ja) 2013-12-25
SI1971588T1 (sl) 2012-11-30
PL1971588T3 (pl) 2013-01-31
US10543188B2 (en) 2020-01-28
AU2006326872C1 (en) 2018-05-17
US20230301960A1 (en) 2023-09-28
US20190099397A1 (en) 2019-04-04
US20210196668A1 (en) 2021-07-01
US20160158187A1 (en) 2016-06-09
HUS2000022I1 (hu) 2020-07-28
FR20C1027I1 (fr) 2020-10-02
US9289410B2 (en) 2016-03-22
PT1971588E (pt) 2012-10-16
US20090182042A1 (en) 2009-07-16
US20140155479A1 (en) 2014-06-05
AU2006326872B9 (en) 2011-09-29
EP1971588B1 (fr) 2012-07-11
CN101384575A (zh) 2009-03-11
US20170143662A1 (en) 2017-05-25
AU2006326872A1 (en) 2007-06-28
CA2634469A1 (fr) 2007-06-28
US12208078B2 (en) 2025-01-28
EP1971588A1 (fr) 2008-09-24
US9770431B2 (en) 2017-09-26
JP2009520699A (ja) 2009-05-28
US8598229B2 (en) 2013-12-03
LUC00164I2 (fr) 2021-08-16
NL301055I2 (nl) 2020-11-25
AU2006326872B2 (en) 2011-08-18
CN101384575B (zh) 2013-05-29
WO2007070985A1 (fr) 2007-06-28
ES2391296T3 (es) 2012-11-23
DK1971588T3 (da) 2012-10-22
US10980769B2 (en) 2021-04-20
HK1122568A1 (en) 2009-05-22

Similar Documents

Publication Publication Date Title
FR20C1027I2 (fr) Derives de tiglien-3-one
CY2022001I1 (el) Παραγωγα του uk-2a
DOP2007000084A (es) Derivados de dihidropirazolopirimidinona
EP1967696A4 (fr) Piece de turbine
CR10562A (es) Nuevos derivados de piridazina
MA28824B1 (fr) Derives de pyrimidine
ATE483711T1 (de) Spiroindolinonderivate
PT1928223E (pt) Singularizador de sementes
ATE512135T1 (de) Spiroindolinonderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
DE602006010581D1 (de) 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
EP1973405A4 (fr) Derives d'hydroxyalkymarylamide
DK2035394T3 (da) 2-pyrazincarboxamidderivater
MA28813B1 (fr) Derives de pyrimidine
EP1896395A4 (fr) Dérivés modifiés du malonate
ATE485294T1 (de) Azaindol-2-carboxamid-derivate
FR2902426B1 (fr) Derives de cinnamoyl-piperazine
ATE487718T1 (de) Substituierte bizyklische pyrimidonderivate
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
EP1906944A4 (fr) Preparation de schisandrine b
CR10809A (es) Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona
DK2086968T3 (da) 5-hydroxymethyl-oxazolidin-2-on-derivater
DOP2006000261A (es) Derivados de 3-alquilazetidina sustituidos con heterociclos
NO20055643D0 (no) Preparation of lodixanol
DE602006014973D1 (de) Neuartige cercosporamidderivate